Status:
COMPLETED
Efficacy of the Nanodropper Device on Pupillary Dilation
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
Nanodropper, Inc.
Conditions:
Dilation
Eligibility:
All Genders
2-17 years
Phase:
NA
Brief Summary
Prescription eye drop bottles elute drops that exceed the capacity of the human eye by five times. This study describes performing in clinic dilation using a novel solution for combating medical waste...
Eligibility Criteria
Inclusion
- Participants under the age of 18 years old
Exclusion
- Participants 18 years and older
- Pupillary or anterior segment abnormality
- Participants with pre-existing health conditions that would prevent pupillary dilation.
Key Trial Info
Start Date :
July 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 19 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05274321
Start Date
July 29 2021
End Date
November 19 2021
Last Update
September 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143